Apnimed, Inc. ·
APMD 8-K 2026-09-08
Apnimed, Inc. (APMD) 8-K dated 2026-09-08 — accession 0001193125-26-385355.
Apnimed, Inc. (APMD) common stock.
APMD: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corp…
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported APMD revenue for 2026-06-30 was $12.1M. Net income was $125.9M. Revenue was down 29.4% from 2025-06-30 to 2026-06-30. APMD currently screens at market cap $692.3M.
Not investment advice. The APMD SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects," "plans," "intends," "may," "could," "might," "should" or other words that convey uncertainty of future events or outc
Why it matters
- expects," "plans," "intends," "may," "could," "might," "should" or other words that convey uncertainty of future events or outc